<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T15:40:18.3172986+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-AGO-Z-UNDP-3</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Multi-Component - Angola (01-Jul-2024-30-Jun-2027)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Angola, Multicomponent, United Nations Development Programme (UNDP Angola)This program has the following goals: Reduce by 50% new infections from HIV/AIDS, among people of all ages, by 2026.  Treat 75% of the persons diagnosed with HIV.  Reduce the mother-to-child transmission rate from 15% in 2022 to 6% in 2026.  Decrease TB incidence from 325 to 261 per 100.000 inhabitants by 2027 (325 per 100,000 is the incidence estimated by WHO in 2021).  By 2025, reduce by 40% malaria morbidity in the country, in relation to the baseline of 2020 (positivity rate in 2020: 52%).  By 2025, reduce by 50% malaria mortality in the country, in relation to the baseline of 2020 (mortality rate by 100,000 in 2020: 38). The objectives of this program are: By 2026, offer HIV combination prevention packages in at least 60% of the municipalities containing the highest HIV incidence rates among the priority population.  By 2026, identify 75% of the persons estimated to be living with HIV and who do not know their status.  By 2026, increase Viral Load Coverage among PLHIV to 75% and to 80% among pregnant women.  Increase the case detection rate of TB by 5% per year (2024-2027).  By 2027, increase the treatment success rate for TB-S from 68% to 78% among adults (5% increase per year during 4 years).  By 2027, all the 82 municipalities with installed mWRD have medical doctors trained in MDR/RR-TB treatment.  By 2027, promote one standard model of C-DOT in all municipalities.  By 2025, provide malaria preventative services to at least 80% of the population at risk.  By 2025, provide early diagnosis and treatment to 100% of malaria suspected cases.  By 2025, strengthen the epidemiological and entomological surveillance systems, and monitoring and evaluation so that 100% of municipalities can achieve their malaria prevention and control targets.  By the end of 2027, 90% of health facilities are reporting their monthly reports..  By the 2027, 90% of health facilities  monthly reports are  submitted timely.</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="AGO-Z-UNDPP03" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="2" />
		<activity-date type="1" iso-date="2024-07-01" />
		<activity-date type="2" iso-date="2024-07-01" />
		<activity-date type="3" iso-date="2027-06-30" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Joshua, GALJOUR</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>joshua.galjour@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="AO" percentage="100">
			<narrative xml:lang="en">Angola</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="28">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12262" percentage="35">
			<narrative xml:lang="en">Malaria</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="19">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="4">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="14">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for AGYW and their male sexual partners programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing outside of KP and AGYW programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Early infant diagnosis and follow-up HIV testing for exposed infants</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Post-natal infant prophylaxis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Comprehensive sexuality education for adolescent girls and young women (AGYW) and adolescent boys and young men (ABYM)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Condom and lubricant programing for AGYW in high HIV incidence settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; HIV prevention communication, information and demand creation for AGYW in high HIV incidence settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Removing human rights-related barriers to prevention for AGYW in high HIV incidence settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Removing human rights-related barriers to prevention for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Condom and lubricant programing for OVP</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Removing human rights-related barriers to prevention for OVP</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programing for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Removing human rights-related barriers to prevention for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programing for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Removing human rights-related barriers to prevention for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and polices relating to HIV and HIV/TB</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy (“Know Your Rights”) (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced disease (adults and children)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Drug resistance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="14">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Case management -&gt; Integrated community case management (iCCM)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; Entomological monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Continuous distribution: ANC</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Continuous distribution: EPI</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="16">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Mass campaign: universal</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; Social and behavior change (SBC) (Vector control)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="20">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health financing systems -&gt; Public financial management (PFM) systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Avoidance, reduction and management of health care waste</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain information systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: HRH planning, management and governance including for community health workers (CHWs)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Quality improvement and capacity building for quality of care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory Information systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory supply chain systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory-based surveillance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: National laboratory governance and management structures</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Network optimization and geospatial analysis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Specimen referral and transport system</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="8">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2024-07-01">35018029.99</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2024-07-01">29522558.26</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2026-01-01" />
			<period-end iso-date="2026-12-31" />
			<value currency="USD" value-date="2024-07-01">40553109.50</value>
		</budget>
		<transaction ref="946de8ea-a769-456e-8710-8b3e1173af31">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-06-18" />
			<value currency="USD" value-date="2024-06-18">56720615.33</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="969c6547-a0b8-4e8e-b62c-2f2ccf19cf9b">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-12-15" />
			<value currency="USD" value-date="2025-12-15">-10370684.26</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="65c49fed-2119-411b-a055-98e6e2adb602">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-12-15" />
			<value currency="USD" value-date="2025-12-15">39701158.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8c927e5d-a8cc-4d86-a50b-cbcdffcc6c59">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-12-03" />
			<value currency="USD" value-date="2024-12-03">9499301.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="aae6ede2-b4f3-4899-bdf3-5c485eb530cc">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-10-15" />
			<value currency="USD" value-date="2024-10-15">4104167.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e984f1d5-658b-4e37-b5b1-74b35cdecfe6">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-06-20" />
			<value currency="USD" value-date="2024-06-20">20447172.07</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e91e7d0a-c4a9-4dbf-8fca-2285e21bbbc9">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-06-11" />
			<value currency="USD" value-date="2025-06-11">3903616.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="50c70759-88b6-424b-8d37-a55574d2f54c">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-08-05" />
			<value currency="USD" value-date="2025-08-05">8395675.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fc3c66ad-56df-4491-bf51-1f16c13034b3">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-12-18" />
			<value currency="USD" value-date="2025-12-18">10227583.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/AGO-Z-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-AGO-Z-UNDP-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Supporting the National Response to HIV/AIDS, Tuberculosis and Malaria in Angola - Angola (01-Jul-2021-30-Jun-2024)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Angola, Multicomponent, United Nations Development Programme (UNDP Angola)This program has the following goals: Reduce new infections, morbidity and mortality from HIV/AIDS  by 2024.  Decrease TB incidence from 355 to 325 per 100.000 inhabitants by 2023 (355 per 100,000 is the incidence estimated by WHO in 2018).  Decrease TB mortality from 7% in 2019 to less than 5% by 2023.  Reduce by 40% the morbidity and mortality of malaria in the 4 provinces by 2025 compared to baseline in 2019. The objectives of this program are: Reduce new HIV infections by at least 20%  among the general population by 2024..  Reduce new HIV infections among children born to HIV infected mothers by 60% by 2024..  Increasing the coverage of PLHIV on ART from 24 % and 15 % in 2019 to 63% and 60% in adults and children, respectively,  by 2024.  Develop a favorable ethical and legal enviroment for reduction of stigma and discrimation against people living and affected by HIV, key and vulnerable population..  Increase the number of notified TB cases from 70.362 in 2018 to 101.530 in 2024.  Increase the  treatment success rate of sensitive TB (all forms) from 25% in 2017 to 85%  in  2024.  Increase the number of notified MDRTB cases from 1,523 in 2019 to 2,848 in 2024..  By 2024, at least 90% of the  population in  target provinces uses LLINs as method of malaria prevention.  By 2024, 100% of suspected malaria cases at health facility, and community levels are tested before receiving treatment..  By  2024, 100% of malaria cases testing positive are treated according to the national guidelines, at all levels of the national health pyramid, including at community level;.  By the end of 2024, 90% of health facilities are reporting their monthly reports..  By the 2024, 90% of health facilities  monthly reports are  submitted timely.</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="AGO-Z-UNDPP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="4" />
		<activity-date type="1" iso-date="2021-07-01" />
		<activity-date type="2" iso-date="2021-07-01" />
		<activity-date type="3" iso-date="2024-06-30" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Joshua, GALJOUR</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>joshua.galjour@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="AO" percentage="100">
			<narrative xml:lang="en">Angola</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="24">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12262" percentage="20">
			<narrative xml:lang="en">Malaria</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="40">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="4">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="12">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 2: Preventing unintended pregnancies among women living with HIV</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Community empowerment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Condom and lubricant programing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Prevention and management of co-infections and co-morbidities (Prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="14">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Prevention and management of co-infections and co-morbidities (Treatment, care and support)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Case management -&gt; Integrated community case management (iCCM)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Specific prevention interventions (SPI) -&gt; Intermittent preventive treatment (IPT) - In pregnancy</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; Entomological monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; Long-lasting insecticidal nets (LLIN) - Continuous distribution - ANC</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; Long-lasting insecticidal nets (LLIN) - Continuous distribution - EPI</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="9">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; Long-lasting insecticidal nets (LLIN) - Mass campaign - Universal</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="12">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Case management, clinical operations and therapeutics</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Country-level coordination and planning</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID diagnostics and testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-based organizations institutional capacity building</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-led advocacy and research</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-led monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Gender-based violence prevention and post violence care (COVID-19)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Health products and waste management systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Infection prevention and control, and protection of the health workforce</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Laboratory systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for HIV programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for Malaria programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for TB programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk communication</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="19">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Avoidance, reduction and management of health care waste</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Procurement capacity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; Laboratory supply chain systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; National laboratory governance and management structures</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Laboratory systems -&gt; Quality management systems and accreditation</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2021-07-01">37718085.09</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2021-07-01">7320611.68</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2021-07-01">42213695.37</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2021-07-01">14150954.33</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2021-07-01">4483236.29</value>
		</budget>
		<transaction ref="602bce76-181e-4c5c-8b45-5be67ac72fb2">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-11-10" />
			<value currency="USD" value-date="2025-11-10">-1078202.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6070623e-014e-42f9-b263-a0555a921fec">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-09-30" />
			<value currency="USD" value-date="2024-09-30">-13230.08</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="abb3571d-6361-442c-ac93-d5fe89a60913">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-07-23" />
			<value currency="USD" value-date="2023-07-23">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="93493e20-1f1f-4474-ba69-1199a2fbd0e7">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-10-01" />
			<value currency="USD" value-date="2021-10-01">-32089090.52</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fbbce355-623f-4258-a71c-013eb9321275">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-10-10" />
			<value currency="USD" value-date="2023-10-10">19345441.33</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="dc53e6e5-c3fc-4c39-b9b3-a92936d34f11">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-10-10" />
			<value currency="USD" value-date="2023-10-10">-9531259.40</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1c38a2be-5fd1-436e-9df9-63eb2df9e2ce">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-02-24" />
			<value currency="USD" value-date="2022-02-24">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9325bd52-2e8a-48c4-8713-ebeb5bc2a861">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-01-10" />
			<value currency="USD" value-date="2024-01-10">14342384.02</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9f600e01-2726-4b22-8293-f3d35f56ed24">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-06-15" />
			<value currency="USD" value-date="2021-06-15">54351000.07</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="59ad667a-71f5-4537-930b-0fad373c1d5b">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-10-01" />
			<value currency="USD" value-date="2021-10-01">52253596.52</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6fad8d76-8231-4e4e-8fd6-471d1e863a16">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-10-07" />
			<value currency="USD" value-date="2021-10-07">12738082.61</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="41ede9d8-3b5b-4df1-9172-8250364f8e36">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-10-01" />
			<value currency="USD" value-date="2024-10-01">-13230.08</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6106e316-ec05-4278-9837-7775ef118843">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-06-18" />
			<value currency="USD" value-date="2024-06-18">2106605.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fed63c78-2115-402f-8631-2528712918bc">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-03-21" />
			<value currency="USD" value-date="2023-03-21">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="55fa9c79-ba35-4d10-bc70-e9514676da13">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-01-16" />
			<value currency="USD" value-date="2024-01-16">3963382.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1cccfa57-041c-4cad-95a4-d3a673c8ef6a">
			<transaction-type code="7" />
			<transaction-date iso-date="2025-11-11" />
			<value currency="USD" value-date="2025-11-11">-1078202.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f42e71cf-734c-4648-8a1d-3e7dc2d03a36">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-07-21" />
			<value currency="USD" value-date="2022-07-21">20024548.51</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5ce8641d-e979-47f3-8a74-c5f00cd00248">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-10-12" />
			<value currency="USD" value-date="2023-10-12">5258327.13</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e4255a39-43f4-48de-a107-58b145bfc47f">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-04-11" />
			<value currency="USD" value-date="2024-04-11">50000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c3635dec-ae43-40df-8456-f6f5cf23c005">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-10-12" />
			<value currency="USD" value-date="2023-10-12">14087114.20</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="676da477-dc16-4d88-9cc8-25677d3d5b60">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-06-16" />
			<value currency="USD" value-date="2021-06-16">22261909.55</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a2f66b96-b594-4a54-827c-909dd93e3af0">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-10-21" />
			<value currency="USD" value-date="2021-10-21">544724.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="26088a93-0ec4-416c-abe7-4cfac4a9857a">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-10-21" />
			<value currency="USD" value-date="2021-10-21">9414982.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c85b8a93-441c-4406-8071-ed9acdc8def5">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-01-16" />
			<value currency="USD" value-date="2024-01-16">8215305.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/AGO-Z-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for AGO-Z-UNDPP02</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="278" />
					<actual value="192" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="611" />
					<actual value="613" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="335" />
					<actual value="240" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="556" />
					<actual value="296" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="278" />
					<actual value="104" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="305.5" />
					<actual value="311" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="305.5" />
					<actual value="302" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="55.00" />
					<actual value="35.90" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="55.00" />
					<actual value="34.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="55.00" />
					<actual value="33.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="40.00" />
					<actual value="29.70" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="40.00" />
					<actual value="32.40" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="40.00" />
					<actual value="31.20" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="55.00" />
					<actual value="30.10" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="55.00" />
					<actual value="30.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="55.00" />
					<actual value="29.90" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="40.00" />
					<actual value="30.40" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="65.00" />
					<actual value="35.70" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="40.00" />
					<actual value="31.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="40.00" />
					<actual value="33.60" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="65.00" />
					<actual value="28.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Proportion of suspected malaria cases that receive a parasitological test in the community</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="91.10" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="83.20" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="72.10" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="77.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="99.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="99.10" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="100.00" />
					<actual value="91.60" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="516762" />
					<actual value="12915" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="1033524" />
					<actual value="88290" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="516762" />
					<actual value="75375" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="542180" />
					<actual value="101433" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="8516" />
					<actual value="8191" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="7808" />
					<actual value="6497" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="48758" />
					<actual value="34938" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="15616" />
					<actual value="14842" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="17032" />
					<actual value="15922" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="89505.5" />
					<actual value="57259" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="7808" />
					<actual value="8345" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="97516" />
					<actual value="66924" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="52796" />
					<actual value="31909" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="44753" />
					<actual value="26462" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="48758" />
					<actual value="31986" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="44752.5" />
					<actual value="30797" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="8771.5" />
					<actual value="7256" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="8516" />
					<actual value="7731" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="98.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="97.20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="100.00" />
					<actual value="98.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="84.10" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="96.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="96.20" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="87.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="82.50" />
					<actual value="65.90" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="75.00" />
					<actual value="60.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="82.50" />
					<actual value="72.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="82.50" />
					<actual value="78.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="75.00" />
					<actual value="66.20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="75.00" />
					<actual value="56.80" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.00" />
					<actual value="65.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="94.90" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="100.00" />
					<actual value="92.70" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="93.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="94.20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="88.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="95.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="84.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="39.00" />
					<actual value="17.70" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="39.00" />
					<actual value="17.70" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="45.00" />
					<actual value="22.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="50.80" />
					<actual value="23.40" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="50.80" />
					<actual value="23.40" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="55.00" />
					<actual value="26.70" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="35.00" />
					<actual value="11.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="85.00" />
					<actual value="66.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="92.00" />
					<actual value="90.70" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="88.80" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="92.00" />
					<actual value="79.70" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="92.00" />
					<actual value="85.40" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="85.00" />
					<actual value="80.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="85.00" />
					<actual value="56.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="68.00" />
					<actual value="59.50" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="28.50" />
					<actual value="28.20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="57.00" />
					<actual value="44.30" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="28.50" />
					<actual value="16.20" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="39.50" />
					<actual value="28.80" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="34.00" />
					<actual value="28.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="34.00" />
					<actual value="30.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="20.00" />
					<actual value="32.30" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="40.00" />
					<actual value="57.90" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="30.00" />
					<actual value="30.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="25.00" />
					<actual value="36.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="20.00" />
					<actual value="25.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="50.00" />
					<actual value="62.90" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="25.00" />
					<actual value="26.60" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="556" />
					<actual value="192" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="335" />
					<actual value="218" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="306" />
					<actual value="264" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="612" />
					<actual value="564" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="278" />
					<actual value="192" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="306" />
					<actual value="300" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="80.00" />
					<actual value="11.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="85.00" />
					<actual value="89.40" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="85.00" />
					<actual value="44.40" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="95.00" />
					<actual value="93.80" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="80.00" />
					<actual value="29.00" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="85.00" />
					<actual value="71.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="80.00" />
					<actual value="52.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="15.00" />
					<actual value="16.50" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="40.00" />
					<actual value="44.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="30.00" />
					<actual value="34.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="25.00" />
					<actual value="25.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="20.00" />
					<actual value="26.40" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="20.00" />
					<actual value="18.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="15.00" />
					<actual value="17.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="55.00" />
					<actual value="59.50" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="39.00" />
					<actual value="26.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="50.00" />
					<actual value="54.20" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="50.00" />
					<actual value="54.20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="35.00" />
					<actual value="22.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="39.00" />
					<actual value="26.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="45.00" />
					<actual value="29.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="50.00" />
					<actual value="43.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="50.00" />
					<actual value="43.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="55.00" />
					<actual value="40.10" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="45.00" />
					<actual value="40.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="40.00" />
					<actual value="40.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="35.00" />
					<actual value="35.40" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="40.00" />
					<actual value="40.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="96.00" />
					<actual value="89.20" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="96.00" />
					<actual value="82.60" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="95.00" />
					<actual value="58.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="95.00" />
					<actual value="60.80" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="96.00" />
					<actual value="86.30" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="96.00" />
					<actual value="86.40" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="95.00" />
					<actual value="56.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="90.00" />
					<actual value="75.40" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="90.00" />
					<actual value="77.20" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="90.00" />
					<actual value="77.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="79.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="83.40" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="77.20" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="79.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="91.40" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="90.00" />
					<actual value="86.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="89.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="90.00" />
					<actual value="91.40" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="84.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="88.20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="90.00" />
					<actual value="91.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="70.00" />
					<actual value="48.90" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="80.00" />
					<actual value="35.70" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="70.00" />
					<actual value="65.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="80.00" />
					<actual value="32.20" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="59.40" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="70.00" />
					<actual value="37.10" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="40.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of pregnant women who know their HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="81.40" />
					<actual value="74.60" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="45.50" />
					<actual value="51.20" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="86.20" />
					<actual value="98.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="40.70" />
					<actual value="37.80" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="43.10" />
					<actual value="44.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="40.70" />
					<actual value="36.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="43.10" />
					<actual value="54.10" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1422288" />
					<actual value="2837430" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="2844576" />
					<actual value="2837430" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="51.00" />
					<actual value="17.50" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="51.00" />
					<actual value="13.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="51.00" />
					<actual value="9.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="39.90" />
					<actual value="5.80" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="63.20" />
					<actual value="6.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="39.90" />
					<actual value="6.70" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="39.90" />
					<actual value="7.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of young people aged 10-24 years reached by comprehensive sexuality education and/or life skills-based HIV education out of schools</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="7.00" />
					<actual value="11.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2022-06-30" />
					<target value="7.00" />
					<actual value="11.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="10.00" />
					<actual value="13.20" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2023-06-30" />
					<target value="10.00" />
					<actual value="13.20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="6.00" />
					<actual value="2.90" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="8.00" />
					<actual value="6.80" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="12.00" />
					<actual value="11.00" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for AGO-Z-UNDPP02</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="55" />
					<actual value="51" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="50" />
					<actual value="53" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="14.00" />
					<actual value="15.19" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="9.00" />
					<actual value="155.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">In-patient malaria deaths: rate per 100,000 persons per year</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="26" />
					<actual value="42.61" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="23" />
					<actual value="38.4" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2.40" />
					<actual value="3.50" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.30" />
					<actual value="4.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1.12" />
					<actual value="1.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1.12" />
					<actual value="0.95" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="345" />
					<actual value="325" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="335" />
					<actual value="333" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Malaria test positivity rate</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="7821490.16" />
					<actual value="7861084" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="7940707.2" />
					<actual value="8326114" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for AGO-Z-UNDPP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="68.00" />
					<actual value="78.98" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="72.00" />
					<actual value="85.29" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="312" />
					<actual value="192.2" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="331" />
					<actual value="200.55" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="69.98" />
					<actual value="33.30" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="27.93" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV who know their HIV status at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="70.00" />
					<actual value="56.25" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="57.67" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-AGO-Z-UNDP-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Supporting the National Response to HIV/aids, Tuberculosis and Malaria in Angola - Angola (01-Jul-2020-30-Jun-2021)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Angola, Multicomponent, United Nations Development Programme (UNDP Angola)This program has the following goals: Reduce by 60% the morbidity and mortality of malaria in the country by 2020 compared to baseline in 2016.  Reduce the  malaria-related mortality (number of malaria deaths per 1000 population)  by 60% from 53,8% in 2016 to 21,5% by 2020.  Reduce TB incidence by 20% by 2021 compared to 2015 level.  Strengthening the national response for the control of STI/HIV and viral Hepatitis to ensure an HIV prevalence rate of less than 3% by 2022.  Reduce TB mortality by 35% by 2021 compared to 2015 level. The objectives of this program are: By the end of 2020, at least 80% of the target population uses an adequate preventive measure against malaria.  Detect 85% of estimated new cases of smear positive TB and achieve a treatment success rate of 85% of all forms smear positive TB cases by 2022.  By the end of 2020, 100% of suspected malaria cases at health facility are tested before receiving treatment;.  Increase the detection rate of MDR TB and treat 100% of diagnosed MDR TB cases by 2022.  By the end of 2020, 100% of malaria cases testing positive are treated according to the national guidelines, at all levels of the national health pyramid.  Ensure 90% of people living with HIV including key and vulnerable populations knows their status by 2022.  Ensure 90% of all people diagnosed with HIV including key and vulnerable populations,  are enrolled, followed and receive timely and efficacious highly active antiretroviral therapy by 2022.  Increase PMTCT coverage from 39% to 90% of HIV positive pregnant women by 2018  2021.  By 2020, strengthen the epidemiology surveillance system, monitoring and evaluation and operational research for Malaria;.  Ensure 90% of all people receiving the antiretroviral therapy including key and vulnerable populations ,attain sustainable viral suppression by 2022.  By 2020, strengthen the management, technical and institutional capacities of the National Malaria Control Program (NMCP) at all levels, to enable efficient and sustainable implementation of the planned activities of the NMCP..  Expand TB/HIV collaborative activities by ensuring that  90% of notified  TB patients are tested for HIV and  100%   who test HIV positive are put on ART promptly and managed.  Strengthen management of a decentralised national TB/HIV response and institute an efficient and integrated M&amp;E system that ensures all indicators listed are tracked and reported timely.</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="AGO-Z-UNDPP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2020-07-01" />
		<activity-date type="2" iso-date="2020-07-01" />
		<activity-date type="3" iso-date="2021-06-30" />
		<activity-date type="4" iso-date="2021-06-30" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Joshua, GALJOUR</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>joshua.galjour@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="AO" percentage="100">
			<narrative xml:lang="en">Angola</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="22">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12262" percentage="27">
			<narrative xml:lang="en">Malaria</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="28">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="12">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="11">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for MSM -&gt; Other intervention(s) for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Addressing stigma, discrimination and violence against sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Behavioral interventions for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; HIV testing services for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Other intervention(s) for sex workers and their clients</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Other intervention(s) for PMTCT</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Community empowerment for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Behavioral change as part of programs for adolescent and youth</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Community mobilization and norms change</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Other intervention(s) for adolescent and youth</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for general population -&gt; Other intervention(s) for general population</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="11">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Other intervention(s) for treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment adherence</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Case management -&gt; Epidemic preparedness</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="24">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Case management -&gt; Other case management intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Specific prevention interventions (SPI) -&gt; Intermittent preventive treatment (IPT) - In pregnancy</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Malaria -&gt; Vector control -&gt; IEC/BCC (Vector control)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="24">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Other community responses and systems intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain infrastructure and development of tools</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Laboratory systems for disease prevention, control, treatment and disease surveillance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service organization and facility management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2020-01-01" />
			<period-end iso-date="2020-12-31" />
			<value currency="USD" value-date="2020-07-01">16042440.87</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2020-07-01">6534649.21</value>
		</budget>
		<transaction ref="3e42b03a-a791-485c-a018-53f2118bc098">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-09-24" />
			<value currency="USD" value-date="2020-09-24">22577090.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7947d6d1-926b-4d50-9e3a-e7f14af3e8f4">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-12-16" />
			<value currency="USD" value-date="2022-12-16">-4374758.12</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f6852de2-b6ea-4b89-9a1c-ef3266c989f9">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-04-09" />
			<value currency="USD" value-date="2021-04-09">87500.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="91107619-dd26-4526-b1d9-062184eab91b">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-11-25" />
			<value currency="USD" value-date="2020-11-25">95360.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9b336795-97fc-4486-82b4-ea76730ab9f6">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-11-04" />
			<value currency="USD" value-date="2020-11-04">22628.75</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="afe6e347-418e-417e-8aaf-c99f113e6b39">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-10-21" />
			<value currency="USD" value-date="2020-10-21">172980.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="aa9f1f39-d665-481a-b783-96234e317119">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-12-16" />
			<value currency="USD" value-date="2020-12-16">20837.25</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0a832e14-95df-4b62-902d-cbf33ec95d33">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-10-02" />
			<value currency="USD" value-date="2020-10-02">14210334.14</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="672ec954-0401-47c1-9bba-0adc1d72f1ea">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-05-21" />
			<value currency="USD" value-date="2021-05-21">3486812.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5b6fd09f-2097-48f4-ae16-7202f05e401d">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-07-01" />
			<value currency="USD" value-date="2021-07-01">51539.74</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cedc7306-0513-40b9-b272-80c33fb9be4d">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-07-01" />
			<value currency="USD" value-date="2021-07-01">54340.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to AGO-Z-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Angola)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/AGO-Z-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for AGO-Z-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="55.00" />
					<actual value="67.10" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="51.00" />
					<actual value="61.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="95.00" />
					<actual value="75.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="95.00" />
					<actual value="80.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adolescent girls and young women (AGYW) reached with HIV prevention programs- defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="1.95" />
					<actual value="4.70" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="1.95" />
					<actual value="2.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="82.00" />
					<actual value="21.50" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="82.00" />
					<actual value="20.40" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="43524" />
					<actual value="29827" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="40739" />
					<actual value="29352" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="1235768" />
					<actual value="335422" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="1235768" />
					<actual value="220226" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="95.00" />
					<actual value="96.30" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="95.00" />
					<actual value="92.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="80.00" />
					<actual value="70.10" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="70.00" />
					<actual value="67.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="9.50" />
					<actual value="7.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="9.50" />
					<actual value="28.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="66.00" />
					<actual value="32.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="80.00" />
					<actual value="34.40" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="77.00" />
					<actual value="67.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="79.00" />
					<actual value="63.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="90.09" />
					<actual value="73.60" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.09" />
					<actual value="86.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="34.78" />
					<actual value="31.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="38.12" />
					<actual value="38.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">CM- Other 1: Proportion of health facilities without stock-out of key commodities (ACTs) during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="94.99" />
					<actual value="18.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="70.00" />
					<actual value="50.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="832.7" />
					<actual value="427" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="952" />
					<actual value="501" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of MSM reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="4.00" />
					<actual value="13.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="4.00" />
					<actual value="2.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Proportion of health facilities without stock-outs of key commodities during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="94.99" />
					<actual value="84.80" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for AGO-Z-UNDPP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Confirmed malaria cases (microscopy or RDT): rate per 1000 persons per year</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="210" />
					<actual value="231.6" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="210" />
					<actual value="231.6" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="1.02" />
					<actual value="1.13" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="62" />
					<actual value="53" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="14.00" />
					<actual value="19.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="2.50" />
					<actual value="2.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB/HIV mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="26" />
					<actual value="8.2" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="359" />
					<actual value="351" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Malaria test positivity rate</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="6026912" />
					<actual value="7283048" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">In-patient malaria deaths: rate per 100,000 persons per year</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="30.5" />
					<actual value="37.1" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for AGO-Z-UNDPP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="75.00" />
					<actual value="30855" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="79.00" />
					<actual value="45864" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="77.00" />
					<actual value="45864" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="72.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="76.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="73.00" />
					<actual value="0.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="70.00" />
					<actual value="58.96" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="251" />
					<actual value="244" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="261" />
					<actual value="244" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="251" />
					<actual value="200.15" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="261" />
					<actual value="200.15" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="47.68" />
					<actual value="39.05" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="70.00" />
					<actual value="70.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="76.00" />
					<actual value="69.65" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>